🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Status
Active Not Recruiting
Location
UAB Nephrology Research Clinic
Start Date
2023-08-08
Trial ID
NCT05797610
Treatments Being Tested
The purpose of this study is to determine if tivantinib (ARQ 197) is effect...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-27
Trial ID
NCT01755767
Treatments Being Tested
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%)...
Status
Completed
Location
Central Contact
Start Date
2017-05-10
Trial ID
NCT03131167
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Terminated
Location
Souseikai Hakata Clinic
Start Date
2018-08-06
Trial ID
NCT03618160
Treatments Being Tested
This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligram...
Status
Terminated
Location
University of Alabama at Birmingham Hospital
Start Date
2019-06-18
Trial ID
NCT03955146
Treatments Being Tested
The aims of the study are: * to assess the safety profile of danavorexton ...
Status
Completed
Location
Endeavor Clinical Trials
Start Date
2021-09-28
Trial ID
NCT05025397
Treatments Being Tested
Migraine is a common neurological disorder typically characterized by attac...
Status
Recruiting
Location
Rehabilitation & Neurological Services /ID# 229969
Start Date
2022-01-13
Trial ID
NCT05125302
Treatments Being Tested
This study is designed to assess the efficacy, safety, and tolerability of ...
Status
Completed
Location
89Bio Clinical Study Site
Start Date
2020-09-01
Trial ID
NCT04541186
Treatments Being Tested
The primary purpose of Part A of this study is to compare, in a single dose...
Status
Completed
Location
USA001
Start Date
2019-01-09
Trial ID
NCT05927597
The study is a Phase I, randomized double-blind, placebo-controlled, single...
Status
Unknown
Location
Seoul National University College of Medicine and Hospital
Start Date
2024-04
Trial ID
NCT06367426
Treatments Being Tested